Haleon (NYSE:HLN) Rating Lowered to “Market Perform” at Sanford C. Bernstein

Sanford C. Bernstein downgraded shares of Haleon (NYSE:HLNFree Report) from an outperform rating to a market perform rating in a report issued on Wednesday morning, MarketBeat.com reports.

HLN has been the subject of several other research reports. UBS Group raised Haleon to a “strong-buy” rating in a report on Tuesday, October 1st. Morgan Stanley upped their target price on Haleon from $9.90 to $10.95 and gave the company an “overweight” rating in a research note on Friday, September 20th. Three research analysts have rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, Haleon currently has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Get Our Latest Stock Analysis on Haleon

Haleon Stock Down 4.0 %

Shares of HLN opened at $9.11 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The company has a 50-day simple moving average of $9.61 and a 200-day simple moving average of $9.67. Haleon has a 52 week low of $7.89 and a 52 week high of $10.80. The firm has a market capitalization of $41.24 billion, a P/E ratio of 26.79, a P/E/G ratio of 2.95 and a beta of 0.29.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HLN. HighTower Advisors LLC boosted its position in Haleon by 27.2% in the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock valued at $3,701,000 after buying an additional 74,970 shares in the last quarter. Jane Street Group LLC boosted its holdings in shares of Haleon by 1,689.4% in the 3rd quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock worth $2,803,000 after acquiring an additional 250,169 shares in the last quarter. Chartwell Investment Partners LLC grew its position in Haleon by 107.8% during the 3rd quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock worth $5,030,000 after acquiring an additional 246,594 shares during the last quarter. Townsquare Capital LLC increased its holdings in Haleon by 29.8% during the 3rd quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock valued at $5,032,000 after purchasing an additional 109,217 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its position in Haleon by 25.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 5,084,202 shares of the company’s stock valued at $53,791,000 after purchasing an additional 1,026,939 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

About Haleon

(Get Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

Further Reading

Analyst Recommendations for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.